MetaCap

Lipocine (LPCN) News

NASDAQ: LPCNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.48-0.02 (-1.33%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

LPCN news summary

We found 3 recent headlines mentioning Lipocine (LPCN): 0 in the past week and 2 in the past 30 days, most often from Nasdaq, PR Newswire. For price context, LPCN is down 1.33% at $1.48. The most recent story, "Lipocine Inc. Reports Third Quarter of 2026 Financial Results and Initiates Phase 3 BLOOM Study", was published by Nasdaq on Nov 6, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Lipocine headlines

Stocks mentioned alongside LPCN

Compare LPCN